Key result
Diabetes-specific nutrition formulas improve glycemic excursions and cardiovascular markers to slow chronic disease progression.
Answers are grounded in this paper and cite their sources.
Food-based dietary management, enhanced with evidence-based commercial products, such as diabetes-specific nutrition formulas (DSNFs), can help control the development, progression, and severity of certain chronic diseases. In this review, evidence is detailed on the use of DSNFs in patients with or at risk for diabetes and cardiometabolic-based chronic disease. Many DSNF strategies target glycemic excursions and cardiovascular physiology, taking into account various elements of healthy eating patterns. Nevertheless, significant research, knowledge, and practice gaps remain. These gaps are actionable in terms of formulating and testing relevant and pragmatic research questions, developing an educational program for the uniform distribution of information, and collaboratively writing clinical practice guidelines that incorporate the evidence base for DSNF. In sum, the benefits of DNSF as part of validated clinical practice algorithms include mitigation of chronic disease progression, cost-savings for the healthcare system, and applicability on a global scale.
No takes yet. Share an insight, caveat, or question.
Mechanick et al. (2020) conducted a review in Diabetes and cardiometabolic-based chronic disease. Diabetes-specific nutrition formulas (DSNFs) was evaluated. Diabetes-specific nutrition formulas target glycemic excursions and cardiovascular physiology to mitigate chronic disease progression and reduce healthcare costs.
Synapse has enriched 10 related papers. Consider them for comparative context: